Analystreport

Gemphire Therapeutics Inc. (NASDAQ: GEMP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $21.00 price target on the stock.

GEMPHIRE THERAPEUTICS INC COMMON  (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com